Avutometinib
id:
avutometinib-257-3105786
title:
Avutometinib
text:
Avutometinib is an inhibitor of Ras-Raf-MEK-ERK signaling being developed as a potential treatment for cancer. It was discovered by Chugai Pharmaceutical Co. through derivatization of a hit compound identified by high-throughput screening. It was licensed by Verastem Oncology in 2020 for clinical trials.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Avutometinib
date created:
date modified:
2023-01-29T22:47:55Z
main entity:
{"identifier":"Q27147976","url":"https://www.wikidata.org/entity/Q27147976"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/c/c9/Avutometinib_ball-and-stick_7MFD.png","width":2909,"height":1500}
fields total:
13
integrity:
15